ALL
The Allstate Corporation
ALL's fundamentals are mixed, but it looks cheap: trading at 6.0x earnings, below its usual 10x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ALL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
ALL's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ALL.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ALL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6x | $267 | — |
| Cheap | 6.2x | $274 | +2.6% |
| Forward | 9.1x | $267 | — |
| Fair | 10x | $450 | +69% |
| Expensive | 16x | $726 | +172% |
Historical ranges are pointers, not guarantees.
ALL's PE is in its cheap range at 6.0x. On analysts' estimates for next year's earnings, today's price would be 9.1x, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ALL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Stable | |
| Weakening | |
| Moderate | |
| Low |
Analysts expect ALL's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ALL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.22 | -34% |
| Q3 2026 | $44.16 | +43% |
| Q2 2026 | $50.08 | +135% |
| Q1 2026 | $45.33 | +210% |
| Q4 2025 | $38.19 | +125% |
| Q3 2025 | $30.89 | +100% |
| Q2 2025 | $21.27 | +94% |
| Q1 2025 | $14.64 | +223% |
| Q4 2024 | $16.99 | +$18.23 |
ALL has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ALL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $17.3B | +0.5% |
| Q2 2026 | $18.6B | +12% |
| Q1 2026 | $16.9B | +3% |
| Q4 2025 | $17.3B | +5.1% |
| Q3 2025 | $17.3B | +3.8% |
| Q2 2025 | $16.6B | +5.8% |
| Q1 2025 | $16.5B | +7.8% |
| Q4 2024 | $16.5B | +11% |
ALL's revenue has grown year over year for 17 quarters in a row: $17.3B last quarter, about level with the same quarter a year ago.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ALL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +15% |
| Q2 2026 | $2.6B | +38% |
| Q1 2026 | $3.5B | +88% |
| Q4 2025 | $2.9B | +75% |
| Q3 2025 | $3.2B | +3.1% |
| Q2 2025 | $1.9B | -19% |
| Q1 2025 | $1.9B | +15% |
| Q4 2024 | $1.7B | +43% |
ALL has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ALL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -3.8M shares |
| 1 year | -4.2% | -11.1M shares |
| 3 years | -2.5% | -6.5M shares |
| 5 years | -14% | -42.6M shares |
| Available history | -23% | -78.2M shares |
ALL has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.1B |
| Q1 2026 | $614M |
| Q4 2025 | $434M |
| Q3 2025 | $360M |
| Q2 2025 | $340M |
| Q1 2025 | $99M |
| Q4 2024 | $2M |
ALL spent $3.3B buying back its own shares over the past year, about four times what it spent the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ALL Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ALL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.7 | Neutral |
| Stochastic | 67.9 | Neutral |
ALL's weekly RSI is 63 (neutral) and its Stochastic is 68 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ALL PE vs Financial Services Sector
| Metric | ALL | Sector median | Relative |
|---|---|---|---|
| PE | 6x | 13x | 54% below |
| PE % | 15 | 63 | 48 pts below |
ALL is trading at 6.0x earnings, a 54% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ALL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $245.4 | 8.7% above |
| 20 week MA | $252.3 | 5.7% above |
| 50 week MA | $227.0 | 17% above |
| 100 week MA | $213.2 | 25% above |
| 200 week MA | $179.8 | 48% above |
ALL has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ALL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $111.9 | $107.2 | -4.2% |
| 2021 | $107.2 | $114.1 | +6.5% |
| 2022 | $114.1 | $136.4 | +19% |
| 2023 | $136.4 | $140.0 | +2.6% |
| 2024 | $140.0 | $193.8 | +38% |
| 2025 | $193.8 | $207.8 | +7.2% |
| 2026 YTD | $207.8 | $266.7 | +28% |
ALL has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.